西拉利珠单抗
Theralizumab | TGN1412 | TAB-08 | TABO8
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg
Product Availability
3-5days
Price
$719.00
Member price
Product Availability
3-5days
Price
$1880.00
Member price
Quantity
- +
Product Overview
Product Name Theralizumab | TGN1412 | TAB-08 | TABO8
CAS906068-56-2
Storage condition store at -20°C | Shipping with blue ice.
Security information
Product details

Theralizumab (TGN1412) is a humanized lgG4 superagonistic anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can cause cytokine release syndrome (CRS). Theralizumab can be used for the research of rheumatoid arthritis.


Related
Sorry, no related items
History
Veratramine (Synonyms: NSC17821; NSC23880; NSC 17821; NSC 23880)
PNU-159682 (Synonyms: PNU 159682)
Otilimab (Synonyms: GSK 3196165; MOR103)
Ursodeoxycholic acid(UDCA);Ursodiol;3,7-Dihydroxycholan-24-oic acid; 3alpha,7beta-Dihydroxy-6beta-cholan-24-oic acid
Vatelizumab (Anti-Integrin a2b1 (ITGA2 & ITGB1))
Clazakizumab (Anti-IL-6 / IFNb2)
Anti-Human F9xF10 Bispecific Antibody(Emicizumab;RO 5534262, ACE 910;RG6013,hBS910;coagulation factor 10, coagulation factor X;coagulation factor 9, coagulation factor IX)
PEAQX | NVP-AAM077
Hyperforin dicyclohexylammonium salt/Hyperforin-DCHA(Hyp-DCHA)
Theralizumab | TGN1412 | TAB-08 | TABO8